当前位置:首页 - 行情中心 - 九强生物(300406) - 财务分析

九强生物

(300406)

  

流通市值:58.87亿  总市值:81.32亿
流通股本:4.24亿   总股本:5.86亿

九强生物(300406)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润1.76亿元,每股收益0.30元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益407278.55万元,未分配利润273084.34万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产544202.42万元,负债136923.86万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入668,335,957.13319,809,793.711,658,931,975.391,237,396,355.82
营业总成本461,501,647.18222,735,370.831,056,135,883.84793,399,425.93
其他经营收益
营业利润196,826,91098,056,421.38624,050,562.29443,677,728.79
利润总额196,384,262.1598,024,052.97620,689,059.36441,532,898.97
净利润175,713,965.1683,572,615.29531,162,206372,402,279
每股收益
其他综合收益-89,167.78-35,824.27280,702.14-163,841.94
综合收益总额175,624,797.3883,536,791.02531,442,908.14372,238,437.06
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计2,447,221,182.222,588,263,932.262,580,998,523.172,597,126,673.95
非流动资产:
非流动资产合计2,994,802,970.283,043,193,655.962,993,966,639.182,860,040,238.91
资产总计5,442,024,152.55,631,457,588.225,574,965,162.355,457,166,912.86
流动负债:
流动负债合计208,697,977.56244,861,231.38278,129,608.55287,588,481.79
非流动负债:
非流动负债合计1,160,540,629.71,171,985,800.331,164,035,605.411,205,030,145.96
负债合计1,369,238,607.261,416,847,031.711,442,165,213.961,492,618,627.75
所有者权益(或股东权益):
归属于母公司股东权益合计4,078,022,542.144,219,983,288.434,138,374,136.023,970,743,202.7
股东权益合计4,072,785,545.244,214,610,556.514,132,799,948.393,964,548,285.11
负债和股东权益合计5,442,024,152.55,631,457,588.225,574,965,162.355,457,166,912.86
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计798,356,728.95366,407,557.921,891,598,392.211,355,254,133.75
经营活动现金流出小计554,280,078.23295,460,843.411,277,586,462.95951,980,056.32
经营活动产生的现金流量净额244,076,650.7270,946,714.51614,011,929.26403,274,077.43
投资活动产生的现金流量:
投资活动现金流入小计43,153,085.7188,602,966.24672,307,553.42274,149,272.89
投资活动现金流出小计236,083,794.81137,138,675.41690,927,208.69236,089,077.71
投资活动产生的现金流量净额-192,930,709.1-48,535,709.17-18,619,655.2738,060,195.18
筹资活动产生的现金流量:
筹资活动现金流入小计4,433,931.57754,865.6129,258,866.2726,176,061.36
筹资活动现金流出小计285,229,023.74,002,806.41205,739,197.57184,779,404.88
筹资活动产生的现金流量净额-280,795,092.13-3,247,940.8-176,480,331.3-158,603,343.52
汇率变动对现金及现金等价物的影响-72,861.86-31,821.43515,978.68197,327.35
现金及现金等价物净增加额-229,722,012.3719,131,243.11419,427,921.37282,928,256.44
期末现金及现金等价物余额901,336,389.471,061,788,964.421,131,058,401.84994,558,736.91
补充资料:
现金及现金等价物的净增加额-229,722,012.37-419,427,921.37-
最新报告期:2025-09-05
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中泰证券谢木青0.700.860.982025-09-05
TOP↑